These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33549391)

  • 1. Aspirin Use and Misuse for the Primary Prevention of Cardiovascular Diseases.
    Luepker RV; Oldenburg NC; Misialek JR; Van't Hof JR; Finnegan JR; Eder M; Duval S
    Am J Prev Med; 2021 Apr; 60(4):513-519. PubMed ID: 33549391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease: A Nonrandomized Controlled Trial.
    Luepker RV; Eder M; Finnegan JR; Van't Hof JR; Oldenburg N; Duval S
    JAMA Netw Open; 2022 May; 5(5):e2211107. PubMed ID: 35536579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.
    Victor K; Skelly M; Mulcahy K; Demler TL; Trigoboff E
    Int Clin Psychopharmacol; 2018 Sep; 33(5):274-281. PubMed ID: 29939889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting.
    Carlton R; Coppolecchia R; Khalaf-Gillard K; Lennert B; Moradi A; Williamson T; Cameron J
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1102-1111. PubMed ID: 30362916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study.
    Van't Hof JR; Duval S; Walts A; Kopecky SL; Luepker RV; Hirsch AT
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin underuse, non-compliance or cessation: definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease.
    Biondi-Zoccai G; Wu Y; Serrano CV; Frati G; Agostoni P; Abbate A
    Int J Cardiol; 2015 Mar; 182():148-54. PubMed ID: 25577751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
    Lin KJ; De Caterina R; García Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?
    Fiscella K; Winters PC; Mendoza M; Noronha GJ; Swanger CM; Bisognano JD; Fortuna RJ
    J Gen Intern Med; 2015 Feb; 30(2):155-60. PubMed ID: 25092016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status and the consistency analysis of using two criteria for decision making of aspirin use for the primary prevention of ischemic cardiovascular disease in outpatients].
    Zuo HJ; Deng LQ; Wang JW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):298-303. PubMed ID: 29747326
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.
    Wolff T; Miller T; Ko S
    Ann Intern Med; 2009 Mar; 150(6):405-10. PubMed ID: 19293073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for Primary Prevention.
    Richman IB; Owens DK
    Med Clin North Am; 2017 Jul; 101(4):713-724. PubMed ID: 28577622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying opportunities to improve aspirin utilization for the primary prevention of cardiovascular disease in a regional health care system.
    VanWormer JJ; Miller AW; Rezkalla H
    WMJ; 2014 Oct; 113(5):190-5; quiz 196. PubMed ID: 25739162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women.
    Rivera CM; Song J; Copeland L; Buirge C; Ory M; McNeal CJ
    J Womens Health (Larchmt); 2012 Apr; 21(4):379-87. PubMed ID: 22303820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of updated recommendations on acetylsalicylic acid use for primary prevention of cardiovascular disease in Canada: a population-based survey.
    Khalili M; Lepeytre F; Guertin JR; Goupil R; Troyanov S; Bouchard J; Madore F
    CMAJ Open; 2020; 8(1):E41-E47. PubMed ID: 31992558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
    J Cardiovasc Risk; 1995 Apr; 2(2):137-42. PubMed ID: 7606650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force.
    Whitlock EP; Burda BU; Williams SB; Guirguis-Blake JM; Evans CV
    Ann Intern Med; 2016 Jun; 164(12):826-35. PubMed ID: 27064261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease.
    Chen Y; Yin C; Li Q; Yu L; Zhu L; Hu D; Sun Y
    Front Cardiovasc Med; 2021; 8():720113. PubMed ID: 34540919
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.
    Mainous AG; Tanner RJ; Shorr RI; Limacher MC
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25023071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.